NCT02530983 Mayo Clinic Upper Digestive Disease Survey
| NCT ID | NCT02530983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Esophageal Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2015-08-15 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2015-08-15 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Mayo Clinic Conduit Report Card Questionnaires have been created in order to have a consistent evaluation tools for patients undergoing esophageal reconstruction or treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data will be used to establish the validation of the questionnaires/survey. Data will also lead to the establishment of "normal" or expected scores for patients undergoing each type of esophagectomy procedure and for upper digestive diseases. Data will contribute to creating treatment algorithms for symptom management for upper digestive diseases and for post-operative complications and symptoms as well as contribute to pre-operative education.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing or having already undergone an esophagectomy or esophageal reconstruction.
Contact & Investigator
Luis Tapias Vargas, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT02530983 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Esophageal Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02530983 currently recruiting?
Yes, NCT02530983 is actively recruiting participants. Contact the research team at AbouChaar.MohamadKhairM@mayo.edu for enrollment information.
Where is the NCT02530983 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT02530983 clinical trial?
NCT02530983 is sponsored by Mayo Clinic. The principal investigator is Luis Tapias Vargas, MD at Mayo Clinic. The trial plans to enroll 1,000 participants.